BROMOCRIPTINE News

BROMOCRIPTINE currently has 8 news articles, with 25 predicted indications.

This page combines the AI-predicted indications for BROMOCRIPTINE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (25):
- hyperpituitarism (99.0%)
- hereditary late onset Parkinson disease (99.0%)
- early-onset parkinsonism-intellectual disability syndrome (99.0%)
- juvenile onset Parkinson disease 19A (99.0%)
- postencephalitic Parkinson disease (99.0%)
- hyperprolactinemia (disease) (99.0%)
- familial hyperprolactinemia (99.0%)
- prolactin producing pituitary gland tumor (99.0%)
- acquired hyperprolactinemia (99.0%)
- acromegaly (99.0%)
- X-linked parkinsonism-spasticity syndrome (99.0%)
- parkinsonian-pyramidal syndrome (99.0%)
- Parkinson disease (99.0%)
- atypical juvenile parkinsonism (99.0%)
- hemiparkinsonism-hemiatrophy syndrome (99.0%)
- congenital disorder of glycosylation with defective fucosylation (99.8%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.8%)
- retinal dystrophy with or without extraocular anomalies (99.8%)
- atypical glycine encephalopathy (99.8%)
- myopia 26, X-linked, female-limited (99.8%)
- hydranencephaly (disease) (99.8%)
- myopia X-linked (99.8%)
- Charcot-Marie-Tooth disease, demyelinating, type 1G (99.8%)
- schizophrenia (99.7%)
- syndromic myopia (99.7%)